TARS vs. CALM
TARS (Tarsus Pharmaceuticals, Inc.) and CALM (Cal-Maine Foods, Inc.) are both stocks. TARS operates in Biotechnology (Healthcare), while CALM operates in Farm Products (Consumer Defensive). Over the past 5 years, TARS returned 15.96%/yr vs 21.91%/yr for CALM. At a 0.03 correlation, their price movements are largely independent.
Performance
TARS vs. CALM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TARS achieves a -22.37% return, which is significantly lower than CALM's -3.25% return.
TARS
- 1D
- 0.63%
- 1M
- 2.09%
- YTD
- -22.37%
- 6M
- -22.47%
- 1Y
- 56.36%
- 3Y*
- 51.58%
- 5Y*
- 15.96%
- 10Y*
- —
CALM
- 1D
- -2.26%
- 1M
- -1.35%
- YTD
- -3.25%
- 6M
- -7.64%
- 1Y
- -21.70%
- 3Y*
- 26.10%
- 5Y*
- 21.91%
- 10Y*
- 9.14%
TARS vs. CALM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
TARS Tarsus Pharmaceuticals, Inc. | -22.37% | 47.88% | 173.43% | 38.13% | -34.84% | -45.56% | 155.12% |
CALM Cal-Maine Foods, Inc. | -3.25% | -15.61% | 87.00% | 14.48% | 51.87% | -1.38% | -1.65% |
Correlation
The correlation between TARS and CALM is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.04 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.04 |
Correlation (All Time) Calculated using the full available price history since Oct 16, 2020 | 0.03 |
Fundamentals
TARS:
$2.73B
CALM:
$3.60B
TARS:
-$1.13
CALM:
$14.48
TARS:
5.07
CALM:
1.05
TARS:
7.82
CALM:
1.33
TARS:
$535.08M
CALM:
$3.46B
TARS:
$483.93M
CALM:
$1.17B
TARS:
-$39.55M
CALM:
$1.05B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TARS vs. CALM — Risk / Return Rank
TARS
CALM
TARS vs. CALM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tarsus Pharmaceuticals, Inc. (TARS) and Cal-Maine Foods, Inc. (CALM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TARS | CALM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.96 | ||
| Sortino ratioReturn per unit of downside risk | +2.96 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 0.90 | +0.34 |
| Calmar ratioReturn relative to maximum drawdown | 1.86 | -0.59 | +2.45 |
| Martin ratioReturn relative to average drawdown | 4.02 | -0.89 | +4.91 |
Loading charts...
Drawdowns
TARS vs. CALM - Drawdown Comparison
The maximum TARS drawdown since its inception was -77.67%, roughly equal to the maximum CALM drawdown of -74.08%. Use the drawdown chart below to compare losses from any high point for TARS and CALM.
Loading charts...
Drawdown Indicators
| TARS | CALM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -77.67% | -74.08% | -3.59% |
Max Drawdown (1Y)Largest decline over 1 year | -30.42% | -37.00% | +6.58% |
Max Drawdown (3Y)Largest decline over 3 years | -47.28% | -37.00% | -10.28% |
Max Drawdown (5Y)Largest decline over 5 years | -63.09% | -37.00% | -26.09% |
Max Drawdown (10Y)Largest decline over 10 years | — | -39.12% | — |
Current DrawdownCurrent decline from peak | -22.97% | -33.05% | +10.08% |
Average DrawdownAverage peak-to-trough decline | -40.46% | -30.31% | -10.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.06% | 24.35% | -10.29% |
Volatility
TARS vs. CALM - Volatility Comparison
Tarsus Pharmaceuticals, Inc. (TARS) has a higher volatility of 8.37% compared to Cal-Maine Foods, Inc. (CALM) at 6.47%. This indicates that TARS's price experiences larger fluctuations and is considered to be riskier than CALM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TARS | CALM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.37% | 6.47% | +1.90% |
Volatility (6M)Calculated over the trailing 6-month period | 28.59% | 20.34% | +8.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 43.79% | 32.76% | +11.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.48% | 32.64% | +25.84% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 64.70% | 31.15% | +33.55% |
Dividends
TARS vs. CALM - Dividend Comparison
TARS has not paid dividends to shareholders, while CALM's dividend yield for the trailing twelve months is around 6.32%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CALM Cal-Maine Foods, Inc. | 6.32% | 10.90% | 2.82% | 7.51% | 3.17% | 0.09% | 0.00% | 0.98% | 1.03% | 0.00% | 2.70% | 4.10% |
TARS Tarsus Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
TARS vs. CALM - Financials Comparison
This section allows you to compare key financial metrics between Tarsus Pharmaceuticals, Inc. and Cal-Maine Foods, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TARS vs. CALM - Profitability Comparison
TARS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Tarsus Pharmaceuticals, Inc. reported a gross profit of 152.66M and revenue of 162.05M. Therefore, the gross margin over that period was 94.2%.
CALM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cal-Maine Foods, Inc. reported a gross profit of 119.28M and revenue of 666.95M. Therefore, the gross margin over that period was 17.9%.
TARS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Tarsus Pharmaceuticals, Inc. reported an operating income of -6.12M and revenue of 162.05M, resulting in an operating margin of -3.8%.
CALM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cal-Maine Foods, Inc. reported an operating income of 35.98M and revenue of 666.95M, resulting in an operating margin of 5.4%.
TARS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Tarsus Pharmaceuticals, Inc. reported a net income of -6.97M and revenue of 162.05M, resulting in a net margin of -4.3%.
CALM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cal-Maine Foods, Inc. reported a net income of 50.46M and revenue of 666.95M, resulting in a net margin of 7.6%.
Frequently Asked Questions
TARS and CALM have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TARS has higher volatility (8.37%) compared to CALM (6.47%). In terms of maximum drawdown, TARS dropped -77.67% vs CALM's -74.08%.
TARS currently has the higher Sharpe Ratio (1.30 vs -0.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TARS and CALM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer